Patents Prosecuted
Application number | Title of the patent | IPC | Filing Date | Decision Date |
---|---|---|---|---|
17811217 | METHODS AND APPARATUS FOR DELIVERY OF OCULAR IMPLANTS | A61F | Jul 6, 2022 | |
17852211 | Animal protein-free pharmaceutical compositions | A61K | Jun 27, 2022 | Dec 12, 2022 |
17835503 | Process and system for obtaining botulinum neurotoxin | C12N, C12R, C07K, C12P, B01D | Jun 7, 2022 | Dec 19, 2022 |
17824428 | INFORMATION PROCESSING APPARATUS, INFORMATION PROCESSING METHOD, AND STORAGE MEDIUM | G06T | May 24, 2022 | |
17824425 | TOPICAL COMPOSITION AND METHOD OF USE | A61Q, A61K | May 24, 2022 | |
17732951 | PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN | C12N, C12P, C07K, B01D | Apr 28, 2022 | Feb 23, 2023 |
17659216 | PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES | A61K | Apr 13, 2022 | |
17713069 | CROSS LINKED SILK-HYALURONIC ACID COMPOSITION | A61K, C08J, C08B, C08L, C08H, A61Q, A61L | Apr 3, 2022 | Dec 26, 2023 |
17694932 | Process and system for obtaining botulinum neurotoxin | C12R, C12N, B01D, C12P, C07K | Mar 14, 2022 | Dec 5, 2022 |
17694962 | PROCESS AND SYSTEM FOR OBTAINING BOTULINUM NEUROTOXIN | B01D, C12N, C12P, C07K | Mar 14, 2022 | Oct 27, 2022 |
17574893 | TOPICAL COMPOSITION AND METHOD OF USE | A61K, A61Q | Jan 12, 2022 | |
17647813 | PRESBYOPIA TREATMENTS | A61P, A61K | Jan 11, 2022 | Nov 16, 2023 |
17573096 | IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS | C12Q, G01N, C07K | Jan 10, 2022 | Feb 7, 2023 |
17644719 | FIXED DOSE COMBINATION OF BRIMONIDINE AND TIMOLOL | A61K | Dec 15, 2021 | |
17545940 | 3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF | A61P, C07B, C07C, C07D | Dec 7, 2021 | |
17457882 | PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANT | A61K, A61L | Dec 5, 2021 | May 17, 2023 |
17457184 | TOPICAL COMPOSITIONS COMPRISING BIMATOPROST AND METHODS FOR STIMULATING HAIR GROWTH THEREWITH | A61K, A61P, A61Q | Nov 30, 2021 | Sep 28, 2023 |
17537474 | DEVICES FOR INJECTION AND DOSING | A61M | Nov 28, 2021 | |
17455375 | SELF-EMULSIFYING DRUG DELIVERY (SEDDS) FOR OPHTHALMIC DRUG DELIVERY | A61K | Nov 16, 2021 | Dec 25, 2023 |
17454746 | NON-IRRITATING TESTOSTERONE EMULSIONS | A61K | Nov 11, 2021 |